A New Wave for Hereditary Breast and Ovarian Cancer

Explore a comprehensive webinar on the latest developments in hereditary breast and ovarian cancer research. Delve into a selective literature review of recent papers, presented by Michelle Jackson, a product manager at Ambry Genetics. Gain insights into various aspects of hereditary cancers, including risk factors, cancer spectrum, and genotype-phenotype correlations. Examine data from studies on PAL2, RAD51, and NF1 genes, as well as information on triple-negative breast cancer and mutation carriers. Learn about the impact of ethnicity, risk modifiers, and family history on cancer susceptibility. Discover Ambry Genetics' panels and their approach to updating genetic testing offerings. Engage with discussions on male breast cancer, internal data studies, and upcoming events in the field. Conclude with a Q&A session addressing panel updates, gene inclusion requests, and specific mutation inquiries.